ON123300 is primarily utilized in the field of cancer research due to its potential as a kinase inhibitor. It has shown promise in targeting specific kinases involved in tumor growth and proliferation, making it a candidate for therapeutic development in various cancers. Researchers are exploring its efficacy in inhibiting pathways that contribute to cancer cell survival, particularly in cases where traditional treatments have limited success. Additionally, ON123300 is being studied for its role in overcoming drug resistance in certain malignancies, offering a potential avenue for combination therapies. Its application extends to preclinical studies, where it aids in understanding the molecular mechanisms of kinase signaling and its impact on cancer progression.